Madisen Reynard
Family Medicine · Bridge City, TXNPI 1174285449
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations.
Across 89 payments — averaging $19.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$396
- Novo Nordisk$297
- AstraZeneca$232
- GSK$120
- Pfizer$93
- Lilly USA, LLC$71
- plus $522 from 18 others
What the payments were for
- Food & beverage$1,730100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $396 |
| Novo Nordisk | 15 | $297 |
| AstraZeneca | 15 | $232 |
| GSK | 5 | $120 |
| Pfizer | 4 | $93 |
| Lilly USA, LLC | 4 | $71 |
| Johnson & Johnson | 2 | $54 |
| Merck | 3 | $53 |
| Bayer | 2 | $49 |
| Baxter Healthcare | 1 | $41 |
| Daiichi Sankyo Inc. | 2 | $37 |
| Sanofi-aventis U.S. LLC | 2 | $34 |
| Kowa Pharmaceuticals America, Inc. | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Sunovion Pharmaceuticals Inc. | 1 | $24 |
| Tris Pharma Inc | 1 | $23 |
| IBSA Pharma Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Exact Sciences | 1 | $22 |
| Medtronic | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $16 |
How this compares
$1,730 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 13 | $226 |
| Azithromycin | 13 | $67 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Bridge City
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.